172 related articles for article (PubMed ID: 12390306)
1. Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance.
Barone KS; Herms B; Karlosky L; Murray S; Qualls J
Clin Exp Immunol; 2002 Nov; 130(2):196-203. PubMed ID: 12390306
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytotoxic T-lymphocyte-associated antigen-4 in the inductive phase of oral tolerance.
Chen Y; Ma Y; Chen Y
Immunology; 2002 Feb; 105(2):171-80. PubMed ID: 11872092
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 12 and costimulators in T cell anergy in vivo.
Van Parijs L; Perez VL; Biuckians A; Maki RG; London CA; Abbas AK
J Exp Med; 1997 Oct; 186(7):1119-28. PubMed ID: 9314560
[TBL] [Abstract][Full Text] [Related]
4. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4 is required for the induction of high dose oral tolerance.
Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
[TBL] [Abstract][Full Text] [Related]
6. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.
Perez VL; Van Parijs L; Biuckians A; Zheng XX; Strom TB; Abbas AK
Immunity; 1997 Apr; 6(4):411-7. PubMed ID: 9133420
[TBL] [Abstract][Full Text] [Related]
7. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
Zhang X; Izikson L; Liu L; Weiner HL
J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
[TBL] [Abstract][Full Text] [Related]
8. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.
Murphy EE; Terres G; Macatonia SE; Hsieh CS; Mattson J; Lanier L; Wysocka M; Trinchieri G; Murphy K; O'Garra A
J Exp Med; 1994 Jul; 180(1):223-31. PubMed ID: 7516409
[TBL] [Abstract][Full Text] [Related]
9. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
10. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
11. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
[TBL] [Abstract][Full Text] [Related]
12. CD2 regulates responsiveness of activated T cells to interleukin 12.
Gollob JA; Li J; Reinherz EL; Ritz J
J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
[TBL] [Abstract][Full Text] [Related]
13. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice.
Hellings PW; Vandenberghe P; Kasran A; Coorevits L; Overbergh L; Mathieu C; Ceuppens JL
Eur J Immunol; 2002 Feb; 32(2):585-94. PubMed ID: 11828376
[TBL] [Abstract][Full Text] [Related]
14. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.
Schwarz A; Beissert S; Grosse-Heitmeyer K; Gunzer M; Bluestone JA; Grabbe S; Schwarz T
J Immunol; 2000 Aug; 165(4):1824-31. PubMed ID: 10925260
[TBL] [Abstract][Full Text] [Related]
15. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
16. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
19. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
20. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
